5:32 PM
 | 
Dec 19, 2012
 |  BC Extra  |  Company News

Amgen to pay $762M for illegal promotion

Amgen Inc. (NASDAQ:AMGN) will pay $612 million to resolve civil liability related to promotional activities for six of its drugs, including...

Read the full 88 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >